رجوع
نطاق اليوم
KWD 9.75
KWD 11.36
نطاق 52 أسبوعًا
KWD 5.00
KWD 15.12
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 10.76
/
KWD 11.34
الإغلاق السابق
KWD 10.77
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -177.3 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | -0.7 | 3.7 |
| Net Margin % | -1.0 | 3.9 |
| Rev Growth 5Y % | 25.1 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 5.700
KWD 3.931 – KWD 9.224
|
41 B | 1 |
| FY2028 |
KWD 5.679
KWD 3.916 – KWD 9.189
|
32 B | 1 |
| FY2027 |
KWD 2.527
KWD 1.743 – KWD 4.089
|
22 B | 1 |
النقاط الرئيسية
Revenue grew 25.12% annually over 5 years — strong growth
Debt/Equity of 0.22 — conservative balance sheet
Negative free cash flow of -418.39M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 26.70%
النمو
Revenue Growth (5Y)
25.12%
Revenue (1Y)51.82%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-0.74%
ROIC-3.55%
Net Margin-1.00%
Op. Margin-8.02%
الأمان
Debt / Equity
0.22
Current Ratio2.35
Interest Coverage-11.17
التقييم
P/E Ratio
-177.30
P/B Ratio1.28
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 51.82% | Revenue Growth (3Y) | 43.80% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 25.12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.42B | Net Income (TTM) | -94.63M |
| ROE | -0.74% | ROA | -0.44% |
| Gross Margin | 83.97% | Operating Margin | -8.02% |
| Net Margin | -1.00% | Free Cash Flow (TTM) | -418.39M |
| ROIC | -3.55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 2.35 |
| Interest Coverage | -11.17 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -177.30 | P/B Ratio | 1.28 |
| P/S Ratio | 1.78 | PEG Ratio | 6.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 16.78B | Enterprise Value | 12.10B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 9.42B | 6.21B | 4.56B | 4.27B | 3.84B |
| Net Income | -94.63M | -1.03B | -2.18B | -2.73B | -998.42M |
| EPS (Diluted) | -0.06 | -0.66 | -1.46 | -1.88 | -0.74 |
| Gross Profit | 7.91B | 4.40B | 3.63B | 3.70B | 3.46B |
| Operating Income | -755.87M | -1.68B | -3.12B | -2.70B | -557.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 21.60B | 20.63B | 17.59B | 16.24B | 11.83B |
| Total Liabilities | 8.48B | 8.10B | 6.86B | 5.91B | 3.06B |
| Shareholders' Equity | 13.12B | 12.53B | 10.73B | 10.33B | 8.78B |
| Total Debt | 2.83B | 3.62B | 3.23B | 2.50B | 1.21B |
| Cash & Equivalents | 7.51B | 10.05B | 1.02B | 1.36B | 1.28B |
| Current Assets | 10.27B | 13.43B | 11.51B | 11.55B | 9.47B |
| Current Liabilities | 4.37B | 4.48B | 3.50B | 3.05B | 1.49B |